Therapy of HBsAg-negative chronic active hepatitis in transfusion-dependent thalassemia major.
D001219:Aspartate Aminotransferases / Q000097:blood; D002648:Child; D002675:Child, Preschool; D003676:Deferoxamine / Q000627:therapeutic use; D006509:Hepatitis B / Q000188:drug therapy / Q000209:etiology; D006514:Hepatitis B Surface Antigens / Q000032:analysis; D006526:Hepatitis C / Q000188:drug therapy / Q000209:etiology; D006521:Hepatitis, Chronic / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D006801:Humans; D007501:Iron / Q000652:urine; D008775:Methylprednisolone / Q000627:therapeutic use*; D013789:Thalassemia / Q000188:drug therapy / Q000628:therapy*; D065227:Transfusion Reaction
D006514:Hepatitis B Surface Antigens; D007501:Iron; D001219:Aspartate Aminotransferases; D003676:Deferoxamine; D008775:Methylprednisolone